Influenza-associated pediatric mortality in the united states: Increase of Staphylococcus aureus coinfection

Pediatrics

Volumn 122, Issue 4, 2008, Pages 805-811

  Finelli, Lyn ^a,b   Fiore, Anthony ^a   Dhara, Rosaline ^a   Brammer, Lynnette ^a   Shay, David K ^a   Kamimoto, Laurie ^a   Fry, Alicia ^a   Hageman, Jeffrey ^a   Gorwitz, Rachel ^a   Bresee, Joseph ^a   Uyeki, Timothy ^a  

^a NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Influenza; Influenza vaccine; Mortality rates; Staphylococcus aureus

Indexed keywords

INFLUENZA VACCINE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CHILD; CHILDHOOD MORTALITY; FEMALE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIXED INFECTION; PNEUMONIA; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; UNITED STATES; ADOLESCENT; AGE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MORTALITY; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STAPHYLOCOCCUS AUREUS; SUPERINFECTION; SURVIVAL RATE;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERINFECTION; SURVIVAL RATE; UNITED STATES;

EID: 54049083410     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1336     Document Type: Article

References (48)

1. Thompson W, Shay D, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11): 1333-1400
2. Thompson W, Shay D, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-186
3. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-239
4. Mullooly JP, Bridges CB, Thompson WW, et al. influenza and RSV-associated hospitalizations among adults. Vaccine. 2007; 25(5):846-855
5. O'Brien MA, Uyeki, TM, Shay DK, et al. incidence of outpatient visits and hospitalizations related to infants and young children. Pediatrics. 2004;113(3 pt 1):585-593
6. McCullers JA. insights into the interaction between influenza virus and Pneumococcus. Clin Microbiol Rev. 2006;19(3):571-582
7. Chickering HT, Park JH. Staphylococcus aureus pneumonia. JAMA. 1919;72:617-626
8. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest. 1959;38(1 pt 2):213-265
9. Bhat, N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559-2567
10. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2007;56(RR-6): 1-54
11. Podewils LJ, Liedtke LA, McDonald C, et al. A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis. 2005;40(11):1693-1696
12. Coffin SE, Zaoudis TE, Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics. 2007; 119(4):740-748
13. MacDonald KL, Osterholm MT, Hedberg CW, et al. Toxic shock syndrome: a newly recognized complication of influenza and influenza-like illness. JAMA. 1987;257(8):1053-1058
14. Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs of fatal Asian influenza. Lancet. 1958;2(7057):1164-1165
15. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23(1 suppl):S87-S97
16. Abramson JS, Lewis JC, Lyles DS, Heller KA, Mills EL, Bass DA. Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro: role in depressed bactericidal activity. J Clin Invest. 1982;69(6):1393-1397
17. Nickerson CL, Jakab GJ. Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect Immun. 1990;58(9):2809-2814
18. Jakab GJ. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia. Am Rev Respir Dis. 1982;126(5):778-782
19. Goslings WR, Mulder J, Djajadiningrat J, Masurel N. Staphylococcal pneumonia in influenza in relation to antecedent staphylococcal skin infection. Lancet. 1959;2(7100):428-430
20. Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006;118(3):874-881
21. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. 2005;353(12):1245-1251
22. Hageman JC, Uyeki TM, Francis JS, et al. Severe communityacquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis. 2006;12(6):894-899
23. Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep. 2007;33(4):45-48
24. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep. 2007;56(14):325-339
25. Jones TF, Creech CB, Erwin P, Baird SG, Woron AM, Schaffner W. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006;42(9):e76-e78
26. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193(2):172-179
27. Nakamura MM, Rohling KL, Shashaty M, Lu H, Tang YW, Edwards KM. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J. 2002;21(10):917-922
28. Fergie J, Purcell K. The epidemic of methicillin-resistant Staphylococcus aureus colonization and infection in children: effects on the community, health systems, and physician practices. Pediatr Ann. 2007;36(7):404-412
29. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in Staphylococcus aureus nasal colonization in the United States, 2001-2004. J Infect Dis. 2008;197(9):1226-1234
30. Creech CB 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24(7):617-621
31. Alfaro C, Mascher-Denen M, Fergie J, Purcell K. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children's Hospital. Pediatr Infect Dis J. 2006;25(5):459-461
32. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006;144(5):309-317
33. Daum RS. Clinical practice: skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007;357(4):380-390
34. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillinresistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674
35. Centers for Disease Control and Prevention. Influenza vaccination coverage among children aged 6-23 months-United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep. 2007;56(37):959-963
36. Centers for Disease Control and Prevention. Influenza vaccination coverage among children aged 6-59 months: six immunization information system sentinel sites, United States, 2006-07 influenza season. MMWR Morb Mortal Wkly Rep. 2007; 56(37):963-965
37. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30- month-old children in day care. Arch Pediatr Adolesc Med. 1995; 149(10):1113-1117
38. Ozgur SK, Beyazova U, Kemaloglu YK, et al. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children. Pediatr Infect Dis J. 2006;25(5):401-404
39. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158(16):1769-1776
40. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001; 20(2):127-133
41. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial: US Oral Neuraminidase Study Group. JAMA. 2000;283(8):1016-1024
42. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza and Streptococcus pneumoniae. J Infect Dis. 2003;187(6):1000-1009
43. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis. 2005;192(2):249-257
44. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45(12):1568-1575
45. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics. 2003;112(2):363-367
46. Guarner J, Paddock CD, Shieh WJ, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis. 2006;43(2):132-140
47. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57(RR-7):3
48. American Academy of Pediatrics Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics. 2007;119(4):852-860